Source · Select Committees · Public Accounts Committee
Recommendation 24
24
Absence of national clinical leadership and outcome monitoring for product use, impacting best practice.
Recommendation
NHSE acknowledged that it does not direct or constrain local decision-making or monitor the use of, or outcomes from use of, a product. As a result, while trusts have the freedom of choice over which products to buy, there is no national leadership or analysis on which products lead to the best outcomes, other than for highly specialised equipment.41 NHS Supply Chain has recently appointed a clinical director but NHSE has not yet appointed a position giving national clinical leadership that can get clinicians to follow agreed national category strategies, as requested by NHS Supply Chain in December 2022.42
Government Response
A response document is linked to this report, dated 28 May 2024. Response attribution to this conclusion has not been verified. Read the response document ↗